Investment analysts at StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
Shares of NASDAQ:CALA opened at $0.00 on Thursday. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.
Calithera Biosciences Company Profile
See Also
- Five stocks we like better than Calithera Biosciences
- How to Use the MarketBeat Stock Screener
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- There Are Different Types of Stock To Invest In
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
